---
$id: https://graph.org.ai/products/commodity/51111630
$type: Product
source: UNSPSC
code: "51111630"
title: "Decitabine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Decitabine

**UNSPSC Code**: 51111630
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a fbxw4 gene with the molecular formula C8H12N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 776B62CQ27, chemically known as 1,3,5-triazin-2(1h)-one, 4-amino-1-(2-deoxy-beta-d-erythro-pentofuranosyl)- but generally known as decitabine, which bears US NIH Compound Identifier 16886. European Medicines Agency schedules Decitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06932MIG. The term DECITABINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules decitabine in its Anatomical Therapeutic Chemical (ATC) Classification. DECITABINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule decitabine under HS 29349990 and SITC 51579. As of Q4 2014, DECITABINE remains the US FDA Preferred Term for this commodity. Decitabine bears US NLM identifiers UMLS ID C0049065 and NCI Concept Code C981. SMILES: O1C(C(O)CC1N1C(=O)NC(NC1)N)CO.

